Vitamin D3 for Life

Live Enlightened

Article

Calcium Availability and Vitamin D Response in Nutritional Rickets: Study Summary

Previous related pageCalcium Availability and Vitamin D Response in Nutritional Rickets: Full StudyNext related pageDiet Patterns and Vitamin D Context
Study at a glance

Did vitamin D help children already receiving calcium for rickets?

The main trial asked whether adding vitamin D helped children already receiving calcium for nutritional rickets. Rickets means that growing bones do not harden properly. Seventy-two Nigerian children with active rickets and very low calcium intake were assigned by chance to calcium plus vitamin D2 or calcium with comparison tablets. This was treatment of established disease, not prevention in healthy children.

How did adding vitamin D affect recovery from rickets?

At 24 weeks, 67% receiving both nutrients and 44% receiving calcium alone met the recovery definition, which required improvement on an X-ray and a blood marker. The direct comparison narrowly missed the usual statistical threshold. An analysis accounting for starting differences favoured combined treatment, but the estimate had a wide range of uncertainty. Earlier recovery at 12 weeks favoured combined treatment. However, one forearm mineral measurement improved more with calcium alone.

What did the supporting rickets and calcium studies show?

One small study found no measurable increase in the percentage of calcium absorbed shortly after vitamin D, despite a rise in active hormone. Another estimated that greater calcium intake could supply more absorbed calcium even as the percentage fell. A calcium-dose trial found different results for X-ray healing and bone density. A separate prevention trial found no overall reduction in rickets or improvement in growth. These studies tested different questions.

Do these results establish a treatment approach for every child?

The evidence suggests faster recovery on some measures, not a uniform improvement in bone health. Higher final vitamin D levels among children who recovered were an association, not proof of an ideal blood target. The studies do not establish a universal supplement combination. The research doses and tested limestone preparation are not instructions for treating a child at home or using untested materials.

Read the full article below ↓

Calcium supply changes what a vitamin D treatment result means. In Nigerian children with established nutritional rickets, adding vitamin D to calcium treatment was associated with earlier recovery, but the final comparison remained uncertain and not every skeletal measurement favoured the combination. This summary explains the main experiment and the evidence needed to interpret it.

What was the treatment question?

Nutritional rickets involves inadequate mineralisation of a child’s growing bones and growth plates. The 2014 trial by Thacher and colleagues asked whether vitamin D added benefit when calcium was already supplied. It did not compare vitamin D alone with no treatment, and it did not test prevention in healthy children.

Seventy-two children with active rickets were allocated by coin toss to calcium plus vitamin D or calcium with comparator tablets. All were older than one year. Median ages were 55 and 42 months in the respective groups, and calcium intake was only about 170 mg/day. Mean starting 25-hydroxyvitamin D, or 25(OH)D, was 30.2 nmol/L. Their nutritional background matters to the question developed in Vitamin D in Nutrient Networks.

Both groups received about 938 mg elemental calcium twice daily as tested limestone. The combined group received 50,000 IU vitamin D₂ every four weeks for 24 weeks. These are research treatment protocols, not instructions for home treatment. Vitamin D dosing was directly observed; calcium adherence was estimated from unused limestone, which could not establish whether every prepared meal was fully eaten.

What counted as recovery?

The main endpoint required an X-ray rickets score of 1.5 or less and alkaline phosphatase of 350 U/L or less. Alkaline phosphatase, an enzyme associated with bone formation, is often raised in active rickets. Combining the measurements meant that structural improvement and a biochemical criterion both had to be present.

At 24 weeks, 29 of 43 children receiving combined treatment met this endpoint, compared with 11 of 25 receiving calcium: 67% versus 44%. The unadjusted comparison had p=0.06. A model accounting for starting alkaline phosphatase, X-ray score, 25(OH)D and height for age gave an odds ratio of 5.4, with a wide 95% confidence interval of 1.3 to 27.

At 12 weeks, the combined endpoint favoured the combination, 26% versus 4.2%, with p=0.03. Adjusted radiographic scores differed significantly at 12 weeks but not at 24 weeks. Conversely, adjusted distal forearm bone mineral gain was greater with calcium alone. The trial therefore suggests faster recovery on some measures, with uncertainty about the final benefit and no uniform skeletal advantage.

Why the blood result is not a target

Children meeting the recovery endpoint had a higher final mean 25(OH)D than nonresponders, 56.4 versus 37.7 nmol/L. This was a meaningful observed association, but the children had not been randomised to those concentrations. Treatment delivery, absorption and other individual differences could influence both the achieved concentration and recovery.

An average among responders cannot identify an optimal concentration for everyone. Nor is the adjusted odds ratio equivalent to a 5.4-fold increase in the probability of recovery. These distinctions are developed in Vitamin D Thresholds vs Targets and in the complete review.

What the supporting experiments change

A 2009 isotope study found no measurable rise in fractional calcium absorption three days after vitamin D in 17 children with rickets, despite higher circulating active hormone. A separate 2008 study found that the fraction absorbed fell during calcium supplementation, while the larger calcium intake was estimated to increase the amount available. Percentage absorbed and milligrams absorbed are different quantities, as explained in Vitamin D and Calcium.

A 2016 calcium-dose trial also produced differing skeletal results. The highest dose did not heal the X-ray abnormalities faster than the middle dose, but it increased forearm shaft areal bone density faster. A 2021 Afghan prevention trial found no overall reduction in rickets or improvement in growth; a dietary-calcium subgroup finding did not establish a treatment interaction. Its younger population and prevention question differ from treatment of established disease.

What the evidence supports

The useful conclusion is that vitamin D response must be interpreted alongside calcium supply and the outcome being measured. These studies do not establish a universal supplement combination, a blood-test target, or a guarantee that adding vitamin D improves every aspect of skeletal recovery. Suspected rickets requires clinical assessment; the tested limestone and treatment doses should not be reproduced with untested materials.

Calcium Availability and Vitamin D Response in Nutritional Rickets: Full Study examines the allocation, adjusted analysis, registration history, absorption methods and contrary skeletal findings in detail.

Primary source and publication details

Related reading

Original sources